Carlos J. V. Simões is a scientist-entrepreneur specializing in translating academic research into new therapies. As co-founder and CTO of BSIM Therapeutics, he leverages his expertise in computational drug discovery and molecular modeling to design treatments for amyloid diseases. He earned his Pharm. D and Ph. D. from the University of Coimbra and conducted research at the University of Leeds.
His professional focus is on developing novel drugs for neurodegenerative diseases, particularly transthyretin-mediated amyloidosis. He is passionate about using high-performance computing and biomolecular simulation to solve complex medical challenges. His work demonstrates a deep commitment to addressing unmet clinical needs through scientific innovation.
Interesting fact: Carlos is an inventor on two patents granted in the US and Europe for compounds designed to inhibit amyloid fibril formation.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.